Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Niagen Bioscience (NAGE) over the last 15 years, with Q3 2025 value amounting to 0.27%.

  • Niagen Bioscience's Return on Capital Employed rose 2600.0% to 0.27% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.27%, marking a year-over-year increase of 2600.0%. This contributed to the annual value of 0.18% for FY2024, which is 3400.0% up from last year.
  • Latest data reveals that Niagen Bioscience reported Return on Capital Employed of 0.27% as of Q3 2025, which was up 2600.0% from 0.26% recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's Return on Capital Employed registered a high of 0.27% during Q3 2025, and its lowest value of 0.88% during Q2 2022.
  • Its 5-year average for Return on Capital Employed is 0.26%, with a median of 0.2% in 2023.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first crashed by -1500bps in 2022, then surged by 6300bps in 2023.
  • Niagen Bioscience's Return on Capital Employed (Quarter) stood at 0.65% in 2021, then increased by 11bps to 0.58% in 2022, then surged by 71bps to 0.17% in 2023, then soared by 204bps to 0.17% in 2024, then surged by 54bps to 0.27% in 2025.
  • Its last three reported values are 0.27% in Q3 2025, 0.26% for Q2 2025, and 0.25% during Q1 2025.